Study of how an osteoporosis shot works in postmenopausal women
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a postmenopausal woman age 45 or older
- Your doctor has prescribed romosozumab for FDA-approved osteoporosis use (high fracture risk or other treatments not tolerated)
- Your postmenopause fits one of these: no natural periods for 36+ months, or 36+ months since hysterectomy (and if under 60, high enough FSH on a blood test)
- Your kidney health is not severe (no stage 4 chronic kidney disease)
- You do not have certain blood and health issues: high parathyroid hormone, low vitamin D, major psychiatric illness, or active substance misuse
- You have not used related osteoporosis medicines recently, and you have never taken romosozumab before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at what medicine works best for women who have finished a 1-year course of a strong bone-building drug (romosozumab or teriparatide) for severe osteoporosis. The goal is to find a good follow-up treatment to keep bones strong and prevent fractures.
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.
This study tests whether a bone-building medication (romosozumab) combined with estrogen replacement therapy can improve bone density in young women with hypothalamic amenorrhea (missing periods due to low energy or stress). It aims to find a better treatment for low bone density caused by this condition.
Hear when a new Osteoporosis, Postmenopausal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.